Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72692 record(s)

Req # A-2020-000448

Adverse Reaction Report (AER). Report number: E2B_03099852.

Organization: Health Canada

9 page(s)
November 2020

Req # A-2020-000461

Adverse Reaction Report (AER) for Pms-Epirubicin. Report number: E2B_02763034.

Organization: Health Canada

15 page(s)
November 2020

Req # A-2020-000467

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03026017.

Organization: Health Canada

9 page(s)
November 2020

Req # A-2020-000476

Adverse Reaction Reports (AERs). Report numbers: 000732496, E2B_02595998, E2B_03063320, E2B_02994441.

Organization: Health Canada

47 page(s)
November 2020

Req # A-2020-000502

Adverse Reaction Reports (AERs) for Dexamethasone. Report numbers: E2B_02615079, E2B_02615949, E2B_02622626, E2B_02624834, E2B_02629779, E2B_02637390, E2B_02646722, E2B_02647594, E2B_02648440, E2B_02659246, E2B_02695461, E2B_02699192, E2B_02725456,…

Organization: Health Canada

195 page(s)
November 2020

Req # A-2020-000503

Adverse Reaction Reports (AERs) for Dexamethasone. Report numbers: E2B_02438885, E2B_02465960, E2B_02696143, E2B_02753981, E2B_02476806, E2B_02664075.

Organization: Health Canada

59 page(s)
November 2020

Req # A-2020-000517

Adverse Reaction Report (AER) for CEFIXIME. Report number: E2B_02868430.

Organization: Health Canada

8 page(s)
November 2020

Req # A-2020-000524

Adverse Reaction Reports (AERs) for FLUDARABINE PHOSPHATE. Report numbers: E2B_01319957, E2B_02957403, E2B_01545734, E2B_02959466, E2B_02893387, 736281, 736290, E2B_02949034, E2B_02951434, E2B_02894317, E2B_02908946, E2B_02431950.

Organization: Health Canada

128 page(s)
November 2020

Req # A-2020-000525

Adverse Reaction Reports (AERs) for FUROSEMIDE. Report numbers: 731475, 734190, 735227, E2B_02845865, E2B_02891064, E2B_02952155.

Organization: Health Canada

128 page(s)
November 2020

Req # A-2020-000526

Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_01013132.

Organization: Health Canada

37 page(s)
November 2020
Date modified: